Integra LifeSciences (IART) Completes Acquisition of Acclarent
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Citi Upgrades Integra LifeSciences (IART) to Neutral
April 3, 2024 5:41 AM EDTCiti analyst Joanne Wuensch upgraded Integra LifeSciences (NASDAQ: IART) from Sell to Neutral with a price target of $38.00.
The analyst comments "Ongoing supply challenges and Boston remediation weigh down expectations, but likely in the stock: upgrading to Neutral from Sell Shares of IART have underperformed YTD, declining 20.3%... More
